255 related articles for article (PubMed ID: 28243981)
21. Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment?
Ortner MA
Curr Gastroenterol Rep; 2001 Oct; 3(5):371-4. PubMed ID: 11560793
[No Abstract] [Full Text] [Related]
22. Changes in screening, prognosis and therapy for esophageal adenocarcinoma in Barrett's esophagus.
Tomizawa Y; Wang KK
Curr Opin Gastroenterol; 2009 Jul; 25(4):358-65. PubMed ID: 19461512
[TBL] [Abstract][Full Text] [Related]
23. [Barrett's esophagus: diagnosis and therapy].
Schmassmann A; Gebbers JO
Praxis (Bern 1994); 2005 May; 94(21):861-8. PubMed ID: 15966485
[TBL] [Abstract][Full Text] [Related]
24. Time to Challenge Current Strategies for Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
Katzka DA; Fitzgerald RC
Dig Dis Sci; 2020 Jan; 65(1):18-21. PubMed ID: 31754994
[No Abstract] [Full Text] [Related]
25. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit.
Moss A; Bourke MJ; Hourigan LF; Gupta S; Williams SJ; Tran K; Swan MP; Hopper AD; Kwan V; Bailey AA
Am J Gastroenterol; 2010 Jun; 105(6):1276-83. PubMed ID: 20179694
[TBL] [Abstract][Full Text] [Related]
26. ASGE guideline on screening and surveillance of Barrett's esophagus.
; Qumseya B; Sultan S; Bain P; Jamil L; Jacobson B; Anandasabapathy S; Agrawal D; Buxbaum JL; Fishman DS; Gurudu SR; Jue TL; Kripalani S; Lee JK; Khashab MA; Naveed M; Thosani NC; Yang J; DeWitt J; Wani S;
Gastrointest Endosc; 2019 Sep; 90(3):335-359.e2. PubMed ID: 31439127
[No Abstract] [Full Text] [Related]
27. New developments in the endoscopic detection and treatment of early neoplasia in Barrett's oesophagus.
Bergman JJ
Scand J Gastroenterol Suppl; 2006; (243):18-24. PubMed ID: 16782618
[No Abstract] [Full Text] [Related]
28. Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barrett's esophagus.
Rosmolen WD; Boer KR; de Leeuw RJ; Gamel CJ; van Berge Henegouwen MI; Bergman JJ; Sprangers MA
Endoscopy; 2010 Jul; 42(7):525-31. PubMed ID: 20539974
[TBL] [Abstract][Full Text] [Related]
29. Managing Barrett's esophagus: what is new in 2005?
Sampliner RE
Dis Esophagus; 2005; 18(1):17-20. PubMed ID: 15773836
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions.
Kroep S; Lansdorp-Vogelaar I; van der Steen A; Inadomi JM; van Ballegooijen M
Med Decis Making; 2015 Aug; 35(6):726-33. PubMed ID: 25277672
[TBL] [Abstract][Full Text] [Related]
31. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
Peitz U; Malfertheiner P
Z Gastroenterol; 2007 Dec; 45(12):1264-72. PubMed ID: 18080229
[TBL] [Abstract][Full Text] [Related]
32. Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus.
Tofani CJ; Gandhi K; Spataro J; Yoo J; Murphy M; Mohan N; Daitch Z; Shah A; Janowski R; Huntley C; Dabbish N; Keith S; Coben R; Cohen S; Kastenberg D; Infantolino A
United European Gastroenterol J; 2019 Mar; 7(2):225-229. PubMed ID: 31080607
[TBL] [Abstract][Full Text] [Related]
33. Evaluation and treatment of superficial esophageal cancer.
DeMeester SR
J Gastrointest Surg; 2010 Feb; 14 Suppl 1():S94-100. PubMed ID: 19760303
[TBL] [Abstract][Full Text] [Related]
34. Advances in diagnosis and management of cancer of the esophagus.
Deboever N; Jones CM; Yamashita K; Ajani JA; Hofstetter WL
BMJ; 2024 Jun; 385():e074962. PubMed ID: 38830686
[TBL] [Abstract][Full Text] [Related]
35. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
Barthel JS; Kucera ST; Lin JL; Hoffe SE; Strosberg JR; Ahmed I; Dilling TJ; Stevens CW
Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
[TBL] [Abstract][Full Text] [Related]
36. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
37. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R; Bonavina L; Bassi F; Peracchia A
Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
[TBL] [Abstract][Full Text] [Related]
38. Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients.
Schmidt HM; Mohiuddin K; Bodnar AM; El Lakis M; Kaplan S; Irani S; Gan I; Ross A; Low DE
Surg Endosc; 2016 Aug; 30(8):3391-401. PubMed ID: 26541725
[TBL] [Abstract][Full Text] [Related]
39. Current state of endoscopic therapies in Barrett's esophagus and esophageal cancer.
Hudson M; Lin CL; Habr F
Hosp Pract (1995); 2011 Feb; 39(1):170-80. PubMed ID: 21441773
[TBL] [Abstract][Full Text] [Related]
40. Barrett's esophagus surveillance: When, how often, does it work?
Katona BW; Falk GW
Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):9-24. PubMed ID: 21112494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
